Ignite Creation Date:
2025-12-24 @ 5:30 PM
Ignite Modification Date:
2025-12-28 @ 4:47 AM
Study NCT ID:
NCT05113368
Status:
RECRUITING
Last Update Posted:
2025-08-21
First Post:
2021-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Sponsor:
Organization: